Biosignature-based tokenization of assets in a blockchain
An apparatus includes a tester to detect a biological signature of a biological sample, a processor, and a memory operably coupled to the processor. The memory stores instructions to cause the processor to receive an indication of the biological signature from the tester, and to generate, using a smart contract and through communication with a distributed ledger, a cryptographic token including a digital identifier based on the biological signature. The cryptographic token is transmitted to a remote processor for verification of the biological sample, in response to receiving the cryptographic token. The tester can detect the biological signature within a predetermined test duration that is less than a DNA sequencing duration associated with the biological sample, and the biological signature has a data precision sufficient to uniquely identify the biological sample from a plurality of biological samples.
1. An apparatus, comprising:
a processor; and
a memory operably coupled to the processor and storing instructions to cause the processor to:
receive an indication of a biological signature from a tester, the biological signature associated with a biological sample and having a data precision sufficient to uniquely identify the biological sample from a plurality of biological samples, the tester configured to detect the biological signature within a predetermined test duration that is less than a DNA sequencing duration associated with the biological sample,
initiate generation, using a smart contract and through communication with a distributed ledger, of a cryptographic token including (1) a digital identifier based on the biological signature, and (2) a representation of at least one of a date, a time, a location, or patient information, and
transmit the cryptographic token to a remote processor configured to verify the biological sample in response to receiving the cryptographic token.
2. The apparatus of claim 1 , wherein the memory further stores instructions to cause the processor to transmit the cryptographic token for storage on the distributed ledger.
3. The apparatus of claim 1 , wherein the memory further stores instructions to cause the processor to transmit the cryptographic token for storage, as a blockchain transaction record, in the distributed ledger, and
the cryptographic token is transmitted to the remote processor such that the remote processor verifies the biological sample by including retrieval of the blockchain transaction record.
4. The apparatus of claim 1 , wherein the biological signature is a disease-agnostic biological signature.
5. The apparatus of claim 1 , wherein the biological sample includes one of blood, urine, saliva, hair, musculoskeletal tissue, or nail.
6. The apparatus of claim 1 , wherein the biological sample includes tumor tissue, and the tester is configured to detect the biological signature of the biological sample using image-based analysis.
7. A system, comprising:
a plurality of apparatuses, each apparatus from the plurality of apparatuses including:
a processor; and
a memory operably coupled to the processor and storing instructions to cause the processor to:
receive, from a tester, a biological signature of a biological sample from a lot of biological samples, the biological signature having a data precision sufficient to uniquely identify the biological sample from a plurality of biological samples, the tester configured to detect the biological signature within a predetermined test duration that is less than a DNA sequencing duration associated with the biological sample;
generate a cryptographic token including (1) a digital identifier based on the biological signature, and (2) a representation of at least one of a date, a time, a location, or patient information, and
transmit the cryptographic token to a remote processor configured to verify the biological sample in response to receiving the cryptographic token.
8. The system of claim 7 , wherein, for each apparatus from the plurality of apparatuses, the memory stores instructions to cause the processor to generate the cryptographic token using a smart contract and through communication with a distributed ledger.
9. The system of claim 7 , wherein, for each apparatus from the plurality of apparatuses:
the tester is configured to perform a first test on the biological sample to detect the biological signature, and
the cryptographic token is transmitted to the remote processor such that the remote processor verifies the biological sample by performing a second test on the biological sample, the second test being substantially the same as the first test.
10. The system of claim 7 , wherein, for each apparatus from the plurality of apparatuses:
the tester is configured to perform a first test on the biological sample to detect the biological signature, and
the cryptographic token is transmitted to the remote processor such that the remote processor verifies the biological sample based on: (1) performing a second test on the biological sample, the second test being substantially the same as the first test, and comparing results of the first test to results of the second test; and (2) at least one of a label or a radio frequency identification (RFID) tag associated with the biological sample.
11. The system of claim 7 , wherein, for each apparatus from the plurality of apparatuses, the cryptographic token is transmitted to the remote processor such that the remote processor verifies the biological sample without using a packaging associated with the biological sample.
12. The system of claim 7 , wherein, for each apparatus from the plurality of apparatuses, the predetermined test duration is less than about one minute.
13. The system of claim 7 , wherein, for each apparatus from the plurality of apparatuses, the biological sample includes at least one of: whole blood, plasma isolate, circulating tumor cells, urine, saliva, hair, musculoskeletal tissue, nail, a resected tumor portion, and a fixed tumor slice.
14. A method, comprising:
receiving a signal representing a cryptographic token including (1) a representation of a biosignature that is associated with a biological sample and that was detected by a tester within a predetermined test duration that is less than a DNA sequencing duration associated with the biological sample, and (2) a representation of at least one of a date, a time, a location, or patient information, the biosignature having a data precision sufficient to uniquely identify the biological sample from a plurality of biological samples;
storing, in response to receiving the signal, a representation of the cryptographic token in a distributed ledger;
storing, in response to receiving the signal, an identifier of the biological sample in the distributed ledger; and
after storing the representation of the cryptographic token and the identifier of the biological sample:
receiving a query including the identifier of the biological sample; and
transmitting, in response to and based on the query, a signal representing the cryptographic token.
15. The method of claim 14 , wherein the query is a first query and the cryptographic token is a first cryptographic token, the first query received from a server associated with an intermediate testing facility, the transmitting the signal representing the cryptographic token being to the server associated with an intermediate testing facility for a first sample verification, the method further comprising:
receiving, from a server associated with a destination facility, a second query including the identifier of the biological sample; and
transmitting, in response to and based on the second query, a signal representing the cryptographic token to the server associated with the destination facility for a second sample verification.
16. The method of claim 15 , further comprising storing chain-of-custody information including data associated with the first sample verification and data associated with the second sample verification.
17. The method of claim 14 , wherein the biosignature is generated using a test methodology, and each of the first sample verification and the second sample verification is performed using the test methodology.
18. The method of claim 14 , wherein the biosignature is a blood plasma analyte analysis biosignature, an image-based analysis biosignature, or a biomechanical analysis biosignature.